Higher-Order Structure and Protein Aggregate Characterization of Protein Therapeutics: Perspectives from Good Manufacturing Practices and Regulatory Guidance-Reference-Cited by-同舟云学术

Higher-Order Structure and Protein Aggregate Characterization of Protein Therapeutics: Perspectives from Good Manufacturing Practices and Regulatory Guidance

Published:2013 Issue: Volume: Page:261-281
ISSN:
Container-title:Biophysics for Therapeutic Protein Development
language:
Short-container-title:

Author:

Struble Evi B.,Cipollo John F.,Kimchi-Sarfaty Chava,Sauna Zuben E.,Ragheb Jack A.,Marszal Ewa

Publisher

Springer New York

Link

http://link.springer.com/content/pdf/10.1007/978-1-4614-4316-2_11

Reference108 articles.

1. Aguzzi A, O’Connor T (2010) Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 9:237–248

2. Alexander PA, He Y, Chen Y, Orban J, Bryan PN (2007) The design and characterization of two proteins with 88 % sequence identity but different structure and function. Proc Natl Acad Sci USA 104:11963–11968

3. Anderson DE, Becktel WJ, Dahlquist FW (1990) pH-induced denaturation of proteins: a single salt bridge contributes 3–5 Kcal/Mol to the free energy of folding of T4 lysozyme. Biochemistry 29:2403–2408

4. Anfinsen CB (1973) Principles that govern the folding of protein chains. Science 181:223–230

5. Appa RS, Theill C, Hansen L, Moss J, Behrens C, Nicolaisen EM, Klausen NK, Christensen MS (2010) Investigating clearance mechanisms for recombinant activated factor VII in a perfused liver model. Thromb Haemost 104:243–51

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regulatory Aspects for Polymeric Micelles;Polymeric Micelles: Principles, Perspectives and Practices;2023